PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7537186-0	1995	Biological variation and the effect of fasting and halothane anesthesia on plasma glutathione S-transferase concentrations.	Halothane	51-60	glutathione S-transferase kappa 1	Homo sapiens	82-107	
1540459-6	1992	Glutathione S-transferase activity was increased significantly in the halothane group throughout the period of study, compared with those who received isoflurane.	Halothane	70-79	glutathione S-transferase kappa 1	Homo sapiens	0-25	
2730828-0	1989	Effect of nicardipine infusion on the release of glutathione S-transferase following halothane anaesthesia.	Halothane	85-94	glutathione S-transferase kappa 1	Homo sapiens	49-74	
3345272-0	1988	Plasma glutathione S-transferase concentration as a measure of hepatocellular integrity following a single general anaesthetic with halothane, enflurane or isoflurane.	Halothane	132-141	glutathione S-transferase kappa 1	Homo sapiens	7-32	
3345272-1	1988	The plasma concentration of hepatic glutathione S-transferase (GST) was measured in matched groups of patients who received halothane, enflurane or isoflurane anaesthesia for elective minor surgery.	Halothane	124-133	glutathione S-transferase kappa 1	Homo sapiens	63-66	
3345272-2	1988	The GST concentrations increased significantly at 3 h after anaesthesia in patients who received halothane or enflurane, but not in patients who were given isoflurane.	Halothane	97-106	glutathione S-transferase kappa 1	Homo sapiens	4-7	
3345272-3	1988	A secondary increase in GST concentration, at 24 h, was seen in a small number of individuals who received halothane or enflurane.	Halothane	107-116	glutathione S-transferase kappa 1	Homo sapiens	24-27	
3345272-4	1988	Abnormal GST concentrations were found in 50% of patients following halothane anaesthesia, 20% following enflurane and 11% after isoflurane.	Halothane	68-77	glutathione S-transferase kappa 1	Homo sapiens	9-12	
3345272-5	1988	The small but significant increases in GST concentrations in patients receiving halothane or enflurane suggests an impairment of hepatocellular integrity following the administration of these anaesthetics.	Halothane	80-89	glutathione S-transferase kappa 1	Homo sapiens	39-42	
3815853-2	1986	Of 20 selected patients, who received halothane for minor urological procedures, 16 showed a small transient rise in GST between 1 h and 3 h after anaesthesia.	Halothane	38-47	glutathione S-transferase kappa 1	Homo sapiens	117-120	
2882183-0	1987	Hepatic glutathione S-transferase release after halothane anaesthesia: open randomised comparison with isoflurane.	Halothane	48-57	glutathione S-transferase kappa 1	Homo sapiens	8-33	
2882183-2	1987	Plasma GST concentrations have been measured by radioimmunoassay in an open randomised study after halothane or isoflurane anaesthesia.	Halothane	99-108	glutathione S-transferase kappa 1	Homo sapiens	7-10	
2882183-3	1987	The concentration of GST was significantly increased after anaesthesia in patients who received halothane in 30% oxygen/70% nitrous oxide (n = 37) and in patients who received halothane in 100% oxygen (n = 17).	Halothane	96-105	glutathione S-transferase kappa 1	Homo sapiens	21-24	
2882183-3	1987	The concentration of GST was significantly increased after anaesthesia in patients who received halothane in 30% oxygen/70% nitrous oxide (n = 37) and in patients who received halothane in 100% oxygen (n = 17).	Halothane	176-185	glutathione S-transferase kappa 1	Homo sapiens	21-24